PuSH - Publication Server of Helmholtz Zentrum München

Stem cell-derived islet therapy: Is this the end of the beginning?

Nat. Rev. Endocrinol. 19, 681-682 (2023)
DOI PMC
The debut of stem cell-derived islets in the clinic for glycaemic control in patients with type 1 diabetes mellitus has garnered much excitement. Ongoing research in this field guarantees to be transformative for modern treatment of diabetes mellitus.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Letter to the Editor
Corresponding Author
ISSN (print) / ISBN 1759-5029
e-ISSN 1759-5037
Quellenangaben Volume: 19, Issue: 12, Pages: 681-682 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place New York, NY
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institut f. Diabetes u. Organoidtech (IDOT)